Design principles for clinical network-based proteomics

Wilson Wen Bin Goh*, Limsoon Wong

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Integrating biological networks with proteomics is a tantalizing option for system-level analysis; for example it can help remove false-positives from proteomics data and improve coverage by detecting false-negatives, as well as resolving inconsistent inter-sample protein expression due to biological heterogeneity. Yet, designing a robust network-based analysis strategy on proteomics data is nontrivial. The issues include dealing with test set bias caused by, for example, inappropriate normalization procedure, devising appropriate benchmarking criteria and formulating statistically robust feature-selection techniques. Given the increasing importance of proteomics in contemporary clinical studies, more powerful network-based approaches are needed. We provide some design principles and considerations that can help achieve this, while taking into account the idiosyncrasies of proteomics data.

Original languageEnglish
Pages (from-to)1130-1138
Number of pages9
JournalDrug Discovery Today
Volume21
Issue number7
DOIs
Publication statusPublished - Jul 1 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Ltd. All rights reserved.

ASJC Scopus Subject Areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Design principles for clinical network-based proteomics'. Together they form a unique fingerprint.

Cite this